U.S. flag

An official website of the United States government

NM_001048174.2(MUTYH):c.409G>A (p.Ala137Thr) AND Familial adenomatous polyposis 2

Germline classification:
Uncertain significance (4 submissions)
Last evaluated:
Mar 19, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000228243.15

Allele description [Variation Report for NM_001048174.2(MUTYH):c.409G>A (p.Ala137Thr)]

NM_001048174.2(MUTYH):c.409G>A (p.Ala137Thr)

Gene:
MUTYH:mutY DNA glycosylase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p34.1
Genomic location:
Preferred name:
NM_001048174.2(MUTYH):c.409G>A (p.Ala137Thr)
HGVS:
  • NC_000001.11:g.45332929C>T
  • NG_008189.1:g.12542G>A
  • NM_001048171.2:c.409G>A
  • NM_001048172.2:c.412G>A
  • NM_001048173.2:c.409G>A
  • NM_001048174.2:c.409G>AMANE SELECT
  • NM_001128425.2:c.493G>A
  • NM_001293190.2:c.454G>A
  • NM_001293191.2:c.442G>A
  • NM_001293192.2:c.133G>A
  • NM_001293195.2:c.409G>A
  • NM_001293196.2:c.133G>A
  • NM_001350650.2:c.64G>A
  • NM_001350651.2:c.64G>A
  • NM_012222.3:c.484G>A
  • NP_001041636.1:p.Ala151Thr
  • NP_001041636.2:p.Ala137Thr
  • NP_001041637.1:p.Ala138Thr
  • NP_001041638.1:p.Ala137Thr
  • NP_001041639.1:p.Ala137Thr
  • NP_001121897.1:p.Ala165Thr
  • NP_001121897.1:p.Ala165Thr
  • NP_001280119.1:p.Ala152Thr
  • NP_001280120.1:p.Ala148Thr
  • NP_001280121.1:p.Ala45Thr
  • NP_001280124.1:p.Ala137Thr
  • NP_001280125.1:p.Ala45Thr
  • NP_001337579.1:p.Ala22Thr
  • NP_001337580.1:p.Ala22Thr
  • NP_036354.1:p.Ala162Thr
  • LRG_220t1:c.493G>A
  • LRG_220:g.12542G>A
  • LRG_220p1:p.Ala165Thr
  • NC_000001.10:g.45798601C>T
  • NM_001048171.1:c.451G>A
  • NM_001128425.1:c.493G>A
  • NR_146882.2:n.637G>A
  • NR_146883.2:n.486G>A
  • p.A165T
Protein change:
A137T
Links:
dbSNP: rs201103359
NCBI 1000 Genomes Browser:
rs201103359
Molecular consequence:
  • NM_001048171.2:c.409G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001048172.2:c.412G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001048173.2:c.409G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001048174.2:c.409G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001128425.2:c.493G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001293190.2:c.454G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001293191.2:c.442G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001293192.2:c.133G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001293195.2:c.409G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001293196.2:c.133G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001350650.2:c.64G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001350651.2:c.64G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_012222.3:c.484G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_146882.2:n.637G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_146883.2:n.486G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
Observations:
3

Condition(s)

Name:
Familial adenomatous polyposis 2
Synonyms:
COLORECTAL ADENOMATOUS POLYPOSIS, AUTOSOMAL RECESSIVE; ADENOMAS, MULTIPLE COLORECTAL, AUTOSOMAL RECESSIVE; MYH-associated polyposis; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0012041; MedGen: C3272841; Orphanet: 220460; OMIM: 608456

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000285952Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Jan 27, 2024)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

SCV000792228Counsyl
criteria provided, single submitter

(Counsyl Autosomal Recessive and X-Linked Classification Criteria (2018))
Uncertain significance
(Jun 13, 2017)
unknownclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link,

SCV004839716All of Us Research Program, National Institutes of Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain Significance
(Jan 11, 2024)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

SCV005056031Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Mar 19, 2024)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown3not providednot provided108544not providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.

Tsaousis GN, Papadopoulou E, Apessos A, Agiannitopoulos K, Pepe G, Kampouri S, Diamantopoulos N, Floros T, Iosifidou R, Katopodi O, Koumarianou A, Markopoulos C, Papazisis K, Venizelos V, Xanthakis I, Xepapadakis G, Banu E, Eniu DT, Negru S, Stanculeanu DL, Ungureanu A, Ozmen V, et al.

BMC Cancer. 2019 Jun 3;19(1):535. doi: 10.1186/s12885-019-5756-4.

PubMed [citation]
PMID:
31159747
PMCID:
PMC6547505

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818
See all PubMed Citations (6)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000285952.11

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 165 of the MUTYH protein (p.Ala165Thr). This variant is present in population databases (rs201103359, gnomAD 0.03%). This missense change has been observed in individual(s) with MUTYH-related conditions (PMID: 31159747). ClinVar contains an entry for this variant (Variation ID: 185959). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Counsyl, SCV000792228.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From All of Us Research Program, National Institutes of Health, SCV004839716.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided3not providednot providedclinical testing PubMed (4)

Description

This missense variant replaces alanine with threonine at codon 165 of the MUTYH protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been performed for this variant. This variant has been reported in individuals affected with breast cancer and kidney renal clear cell carcinoma (PMID: 25186627, 26689913, 33471991). This variant has been detected in a breast cancer case-control meta-analysis in 4/60466 breast cancer cases and 11/53461 controls (PMID: 33471991). This variant has also been identified in 12/281892 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknown108544not providednot provided3not providednot providednot provided

From Baylor Genetics, SCV005056031.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 20, 2024